CXCL9 and neoplasm: Activation of this pathway results in the release of chemokines such as CCL5, CXCL9, and CXCL10, which recruit immune cells—including CD8+ T lymphocytes, macrophages, and dendritic cells—into the tumour microenvironment [6].